{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:59Z","timestamp":1791219599725,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"vor","delay-in-days":2729,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0\/uk\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1093\/nar\/gkp226","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T00:18:36Z","timestamp":1239841116000},"page":"3660-3669","source":"Crossref","is-referenced-by-count":26,"title":["Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase"],"prefix":"10.1093","volume":"37","author":[{"given":"Alexandra","family":"Kataropoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bovolenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Trabatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Garbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Porcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"key\n\t\t\t\t20170510092817_B1","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1128\/JVI.66.11.6489-6495.1992","article-title":"Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes","volume":"66","author":"Gabuzda","year":"1992","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170510092817_B2","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1128\/JVI.67.10.6322-6326.1993","article-title":"Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1","volume":"67","author":"Sova","year":"1993","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B3","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1128\/JVI.67.8.4945-4955.1993","article-title":"Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells","volume":"67","author":"von Schwedler","year":"1993","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170510092817_B5","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1128\/JVI.78.11.6073-6076.2004","article-title":"Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication","volume":"78","author":"Zheng","year":"2004","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170510092817_B7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein","volume":"300","author":"Lecossier","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170510092817_B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170510092817_B9","doi-asserted-by":"crossref","first-page":"35822","DOI":"10.1074\/jbc.M405761200","article-title":"Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs","volume":"279","author":"Svarovskaia","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170510092817_B11","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.77.21.11398-11407.2003","article-title":"The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity","volume":"77","author":"Kao","year":"2003","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B12","first-page":"21","article-title":"Ubiquitination of APOBEC3G by an HIV-1 Vif-cullin5-elonginB-elonginC complex is essential for Vif function","volume":"21","author":"Kobayashi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170510092817_B14","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1074\/jbc.M313093200","article-title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway","volume":"279","author":"Mehle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170510092817_B16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2006.03.027","article-title":"Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products","volume":"351","author":"Carr","year":"2006","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170510092817_B17","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.70.12.8263-8269.1996","article-title":"Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins","volume":"70","author":"Fouchier","year":"1996","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B18","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1128\/JVI.77.10.5810-5820.2003","article-title":"Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions","volume":"77","author":"Gaddis","year":"2003","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1099\/0022-1317-78-3-627","article-title":"Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in \u2018non-permissive\u2019 T lymphoid cells stably infected with selectable HIV-1","volume":"78","author":"Ochsenbauer","year":"1997","journal-title":"J. Gen. Virol."},{"key":"key\n\t\t\t\t20170510092817_B20","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JVI.69.4.2058-2067.1995","article-title":"Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity","volume":"69","author":"Borman","year":"1995","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B21","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1128\/JVI.74.23.11055-11066.2000","article-title":"Role of Vif in stability of the human immunodeficiency virus type 1 core","volume":"74","author":"Ohagen","year":"2000","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1128\/JVI.67.3.1663-1666.1993","article-title":"Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles","volume":"67","author":"Sakai","year":"1993","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B23","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1128\/JVI.69.4.2068-2074.1995","article-title":"Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps","volume":"69","author":"Courcoul","year":"1995","journal-title":"J. Virol."},{"issue":"Pt 8","key":"key\n\t\t\t\t20170510092817_B24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1099\/0022-1317-79-8-1945","article-title":"The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis","volume":"79","author":"Nascimbeni","year":"1998","journal-title":"J. Gen. Virol."},{"key":"key\n\t\t\t\t20170510092817_B25","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1128\/JVI.70.8.5297-5305.1996","article-title":"The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes","volume":"70","author":"Simon","year":"1996","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/JVI.70.1.494-507.1996","article-title":"Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein","volume":"70","author":"Karczewski","year":"1996","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B27","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.75.16.7252-7265.2001","article-title":"Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA","volume":"75","author":"Khan","year":"2001","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B28","doi-asserted-by":"crossref","first-page":"26361","DOI":"10.1074\/jbc.M703122200","article-title":"RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study","volume":"282","author":"Bernacchi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B29","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1128\/JVI.74.19.8938-8945.2000","article-title":"Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription","volume":"74","author":"Dettenhofer","year":"2000","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jmb.2005.09.025","article-title":"Cooperative and specific binding of Vif to the 5\u2032 region of HIV-1 genomic RNA","volume":"354","author":"Henriet","year":"2005","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170510092817_B31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2007.10.041","article-title":"Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription","volume":"372","author":"Carr","year":"2008","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170510092817_B32","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1128\/JVI.74.18.8252-8261.2000","article-title":"Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process","volume":"74","author":"Zhang","year":"2000","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20040914","article-title":"Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass","volume":"383","author":"Cancio","year":"2004","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170510092817_B34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ymthe.2005.05.014","article-title":"T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner","volume":"12","author":"Vallanti","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170510092817_B35","article-title":"(in press) The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.","volume-title":"Blood","author":"Porcellini"},{"key":"key\n\t\t\t\t20170510092817_B36","doi-asserted-by":"crossref","first-page":"33177","DOI":"10.1074\/jbc.M402062200","article-title":"The interaction between HIV-1 Gag and APOBEC3G","volume":"279","author":"Cen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B37","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M602413200","article-title":"A zinc-binding region in Vif binds Cul5 and determines cullin selection","volume":"281","author":"Mehle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jmb.2007.07.029","article-title":"Characterization of a novel Cullin5 binding domain in HIV-1 Vif","volume":"373","author":"Xiao","year":"2007","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170510092817_B39","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1093\/nar\/gkm542","article-title":"Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription","volume":"35","author":"Henriet","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170510092817_B40","doi-asserted-by":"crossref","first-page":"13235","DOI":"10.1128\/JVI.00204-07","article-title":"Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding","volume":"81","author":"Mehle","year":"2007","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B41","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.00395-07","article-title":"Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F","volume":"81","author":"Russell","year":"2007","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1039\/b612050d","article-title":"Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation","volume":"5","author":"Lv","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"key\n\t\t\t\t20170510092817_B43","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines","volume":"18","author":"Yu","year":"2004","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170510092817_B44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-4690-4-81","article-title":"The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G","volume":"4","author":"Miller","year":"2007","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20170510092817_B45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.6026\/97320630001290","article-title":"Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif)","volume":"1","author":"Balaji","year":"2006","journal-title":"Bioinformation"},{"key":"key\n\t\t\t\t20170510092817_B46","article-title":"(in press) The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state","volume-title":"Protein Eng. Des. Sel","author":"Reingewertz"},{"key":"key\n\t\t\t\t20170510092817_B47","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/JVI.69.7.4582-4586.1995","article-title":"Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes","volume":"69","author":"Simm","year":"1995","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B48","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1128\/JVI.74.6.2594-2602.2000","article-title":"Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription","volume":"74","author":"Dornadula","year":"2000","journal-title":"J. Virol."},{"key":"key\n\t\t\t\t20170510092817_B49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","article-title":"Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif","volume":"114","author":"Mariani","year":"2003","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170510092817_B50","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1496","article-title":"Small-molecule inhibition of HIV-1 Vif","volume":"26","author":"Nathans","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170510092817_B51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1371\/journal.ppat.0010006","article-title":"Natural variation in Vif: differential impact on APOBEC3G\/3F and a potential role in HIV-1 diversification","volume":"1","author":"Simon","year":"2005","journal-title":"PLoS Pathog."},{"key":"key\n\t\t\t\t20170510092817_B52","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1093\/nar\/gkm750","article-title":"Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G","volume":"35","author":"Iwatani","year":"2007","journal-title":"Nucleic Acids Res."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/37\/11\/3660\/16753163\/gkp226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:46:27Z","timestamp":1589723187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article-lookup\/doi\/10.1093\/nar\/gkp226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,4,15]]},"published-print":{"date-parts":[[2009,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkp226","relation":{},"ISSN":["1362-4962","0305-1048"],"issn-type":[{"value":"1362-4962","type":"electronic"},{"value":"0305-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}